312
Participants
Start Date
August 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
Alogliptin and glimepiride
Alogliptin 12.5 mg, tablets, orally, once daily and glimepiride 1, 2, 3 or 4 mg, tablets, orally, once or twice daily for up 12 weeks.
Alogliptin and glimepiride
Alogliptin 25 mg, tablets, orally, once daily and glimepiride 1, 2, 3 or 4 mg, tablets, orally, once or twice daily for up 12 weeks.
Glimepiride
Glimepiride 1, 2, 3 or 4 mg, tablets, orally, once or twice daily and alogliptin placebo-matching tablets, orally, once daily for up 12 weeks.
Lead Sponsor
Takeda
INDUSTRY